CDEK
← All drugs Report issue

gw273225

Small moleculeexperimental

Clinical trial activity

3 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2006 (NCT00567424)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • gw273225

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00501865Phase 1Aug 1, 2007GlaxoSmithKline
NCT00483535Phase 1Mar 1, 2007GlaxoSmithKline
NCT00567424Phase 2Jul 1, 2006GlaxoSmithKline
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GlaxoSmithKlineFor profit3322006
1 organizations
Page 1 / 1